$1.37
0.1512.20%
Last update: Dec 16, 10:19 AM
Comments
Loading...
Health In Tech Analyst Ratings and Price Targets | NASDAQ:HIT | Benzinga
Health In Tech Inc has a consensus price target of $2.5 based on the ratings of 1 analysts. The high is $2.5 issued by Maxim Group on June 26, 2025. The low is $2.5 issued by Maxim Group on June 26, 2025. The 1 most-recent analyst ratings were released by Maxim Group on June 26, 2025, respectively. With an average price target of $2.5 between Maxim Group, there's an implied 82.63% upside for Health In Tech Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Maxim Group
1calculated from analyst ratings
Analyst Ratings for Health In Tech
FAQ
What is the target price for Health In Tech (HIT) stock?
The latest price target for Health In Tech (NASDAQ:HIT) was reported by Maxim Group on June 26, 2025. The analyst firm set a price target for $2.50 expecting HIT to rise to within 12 months (a possible 82.63% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Health In Tech (HIT)?
The latest analyst rating for Health In Tech (NASDAQ:HIT) was provided by Maxim Group, and Health In Tech initiated their buy rating.
When was the last upgrade for Health In Tech (HIT)?
There is no last upgrade for Health In Tech
When was the last downgrade for Health In Tech (HIT)?
There is no last downgrade for Health In Tech.
When is the next analyst rating going to be posted or updated for Health In Tech (HIT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Health In Tech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Health In Tech was filed on June 26, 2025 so you should expect the next rating to be made available sometime around June 26, 2026.
Is the Analyst Rating Health In Tech (HIT) correct?
While ratings are subjective and will change, the latest Health In Tech (HIT) rating was a initiated with a price target of $0.00 to $2.50. The current price Health In Tech (HIT) is trading at is $1.37, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
